Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALMR Alamar Biosciences

Pre-Mkt 05-08 04:49:21 EDT

23.66

-0.18

-0.76%

High24.12	Low22.75	Vol270.07K
Open23.85	D1 Closing23.84	Amplitude5.75%
Mkt Cap1.61B	Tradable Cap221.81M	Total Shares68.21M
T/O6.27M	T/O Rate2.88%	Tradable Shares9.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences","latestPrice":23.66,"timestamp":1778184000000,"preClose":23.84,"halted":0,"volume":270070,"delay":0,"changeRate":-0.007550335570469787,"floatShares":9375000,"shares":68208900,"eps":-2.475102,"marketStatus":"Pre-Mkt","change":-0.18,"latestTime":"05-08 04:49:21 EDT","open":23.85,"high":24.12,"low":22.75,"amount":6274581.14162,"amplitude":0.057466,"askPrice":24.8,"askSize":270,"bidPrice":23.66,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.475102,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778247000000},"marketStatusCode":1,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":23.66,"postHourTrading":{"tag":"盘后","latestPrice":23.66,"preClose":23.66,"latestTime":"17:41 EDT","volume":61,"amount":1444.1797,"timestamp":1778190061963,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1236324367104251},"requestUrl":"/m/hq/s/ALMR/wiki","defaultTab":"wiki","newsList":[{"id":"2633262549","title":"Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2633262549","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633262549?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:12","pubTimestamp":1778011930,"startTime":"0","endTime":"0","summary":"Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference on May 12 in Las Vegas.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7sc6YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863902.USD","LU1894683348.USD","SG9999014013.SGD","LU2210150020.SGD","IE00B7SZLL34.SGD","LU0306807586.USD","BAC","LU0306806265.USD","LU0321505868.SGD","LU1804176565.USD","NDAQ","LU2129689514.USD","LU0971096721.USD","LU0417517546.SGD","IE00BZ1G4Q59.USD","BK4588","LU0256863811.USD","SG9999014021.USD","LU0234570918.USD","LU1880398471.USD","ALMR","LU0648000940.SGD","BK4504","LU0648001328.SGD","LU1883839398.USD","LU0203345920.USD","LU0321505439.SGD","LU2095319765.USD","LU0106831901.USD","LU0052756011.USD","IE00B64PRP62.GBP","LU0320765489.SGD","LU0310800965.SGD","LU1496350171.SGD","LU0640476718.USD","LU0170899867.USD","IE00BBT3K403.USD","IE00BN0W2V16.EUR","LU1894683264.USD","LU0130518102.USD","LU0098860793.USD","LU1366192091.USD","LU0053666078.USD","LU2129689605.HKD","BK4207","IE00BKVL7J92.USD","IE00BN0W2W23.USD","LU2265009873.SGD","IE00BLSP4452.SGD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932017","title":"Biotech firm Odyssey targets $810 million valuation in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932017","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632932017?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:48","pubTimestamp":1777891715,"startTime":"0","endTime":"0","summary":"UPDATE 2-Biotech firm Odyssey targets $810 million valuation in US IPOAdds details throughout. May 4  - Biopharmaceutical company Odyssey Therapeutics said on Monday it is targeting a valuation of up to $809.9 million in its initial public offering in the United States, as investors warm up to drug developers. The Boston-based company is seeking to raise up to $238.3 million by offering 13.2 million shares priced between $16 and $18 apiece. The U.S. IPO market has made a strong comeback in recent weeks, setting the stage for a pickup in listings in coming months.Last month, weight-loss drug developer Kailera Therapeutics KLRA.O, Alamar Biosciences ALMR.O and nuclear reactor maker X-Energy XE.O made stellar market debuts.April marked the biggest month for new filings in more than four years, according to Renaissance Capital, a provider of IPO-focused research and ETFs. This despite a volatile first quarter amid a sell-off in tech stocks, private credit strains and the Middle East confli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4N41H0NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDQ","LU0345768740.USD","NVDO","IE000YTNTUN2.SGD","LU0072462426.USD","SNVD.UK","LU0158827948.USD","LU2552382132.HKD","NVDU","BK4533","2NVD.UK","LU1803068979.SGD","NVDS.UK","NVII","ANV","KLRA","NVDL","LU0345768153.USD","IE00B3SWFQ91.USD","LU1934455277.USD","LU2236285917.USD","LU0310799852.SGD","LU1153585028.USD","LU1267930490.SGD","BK4532","NVIW.SI","NVDS","NVD3.UK","LU2420271590.USD","NVDB","LU0965509283.SGD","LU1989772923.USD","SGXZ81514606.USD","LU0061474705.USD","NVD2.UK","NVDY","ALMR","NVDX","LU2756315664.SGD","XE","LU0724617625.USD","SGXZ23171101.USD","DIPS","LU0265550359.USD","NVD","NVDG","NVDA","NVDW","3NVD.UK","NVDD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632650975","title":"Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2632650975","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632650975?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:05","pubTimestamp":1777568757,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (NasdaqGS:ALMR) has been added to the NASDAQ Composite Index, increasing its visibility among index-tracking investors.\nThe company has also filed a new shelf registration, creating flexibility to raise capital in the future if management chooses.\nShares most recently closed at $24.48, with a year-to-date return of 11.3%.\n\nFor you as an investor, the NASDAQ Composite inclusion means Alamar Biosciences now sits on the radar of more funds that track or reference this index...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-almr/alamar-biosciences/news/alamar-biosciences-index-debut-and-shelf-filing-reshape-inve","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-almr/alamar-biosciences/news/alamar-biosciences-index-debut-and-shelf-filing-reshape-inve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QQQA","GPIQ","PSQ","QQQY","ALMR","SQQQ","QQQE","MNQmain","JEPQ","IYW","QYLG","FTEC","TQQQ","QQQ","QQQJ",".IXIC","NQmain","BK4121","QQQM","QLD","ONEQ","QID","NVIW.SI","TQQY","QDTE","NDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629770819","title":"Alamar director Nicholas Naclerio reports acquisition of 235,294 common shares for $4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629770819","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629770819?lang=en_us&edition=fundamental","pubTime":"2026-04-21 08:32","pubTimestamp":1776731546,"startTime":"0","endTime":"0","summary":"Alamar Biosciences director Nicholas Naclerio reported a change in beneficial ownership tied to Illumina Innovation Fund II.Holdings shifted into 5,856,536 shares of common stock held indirectly.Illumina Innovation Fund III reported indirect ownership of 507,076 shares of common stock, including a purchase of 235,294 shares at USD 17.Naclerio also reported receipt of 5,686 restricted stock units.Form also showed a grant of 25,599 stock options with an exercise price of USD 17.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alamar Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL3pgBm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alamar director Nicholas Naclerio reports acquisition of 235,294 common shares for $4 million","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629577560","title":"Alamar Biosciences adopts amended and restated bylaws ahead of IPO close","url":"https://stock-news.laohu8.com/highlight/detail?id=2629577560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629577560?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:04","pubTimestamp":1776715456,"startTime":"0","endTime":"0","summary":"Alamar Biosciences adopted amended and restated bylaws effective April 20, 2026 in connection with IPO closing.Board and stockholders had authorized bylaw changes to take effect immediately prior to IPO close.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alamar Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL358Qhm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115536918","title":"Stock Track | Alamar Biosciences Soars 5% Intraday Following Successful NASDAQ IPO Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1115536918","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115536918?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:16","pubTimestamp":1776694619,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) saw its stock price soar by 5.00% during intraday trading on Monday, reflecting strong investor interest in the newly listed company.The surge follows the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628871890","title":"Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2628871890","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628871890?lang=en_us&edition=fundamental","pubTime":"2026-04-20 10:36","pubTimestamp":1776652560,"startTime":"0","endTime":"0","summary":"Qiming Venture Partners led Alamar's Series A financing in 2020 and continued to fund the company's development in the following Series B and Series C rounds. Before the company's IPO, Qiming Venture Partners held approximately 19.2% stake in Alamar and was one of its most important institutional investors.Founded in 2018, Alamar is a commercial-stage proteomics company dedicated to developing and commercializing proteomics technologies and establishing the gold standard in protein detection and analysis. Alamar's self-developed NULISA technology breaks through the design limitations of existing proteomics tools, delivering ultra-high sensitivity, high specificity, flexible multiplex protein detection, broad dynamic range and seamless automation to detect protein biomarkers at extremely low concentrations, filling a critical gap previously uncovered by other protein detection methods.Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfol","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/precision-proteomics-leader-alamar-biosciences-lists-on-nasdaq-302746795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999006266.SGD","BK6062","QQQA","SG9999001135.SGD","QQQM",".IXIC","NDX","SG9999004360.SGD","NQmain","QLD","SQQQ","QDTE","SG9999014492.USD","FTEC","TQQQ","QID","SG9999014484.SGD","JEPQ","NVIW.SI","SG9999008742.SGD","PSQ","QQQ","V03.SI","IYW","TQQY","BK6515","QYLG","SG9999004220.SGD","QQQY","ALMR","GPIQ","QQQJ","ONEQ","QQQE","SG9999000475.SGD","SG9999001846.SGD","MNQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628073845","title":"Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today","url":"https://stock-news.laohu8.com/highlight/detail?id=2628073845","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628073845?lang=en_us&edition=fundamental","pubTime":"2026-04-18 08:10","pubTimestamp":1776471012,"startTime":"0","endTime":"0","summary":"20:08 EDT Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences (ALMR) today Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-537-5k-shares-of-alamar-biosciences-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-537-5k-shares-of-alamar-biosciences-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKX","SARK","ARKQ","ARKG","ARKK","BK4544","BK4588","ARKF","ARKW","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111071379","title":"Alamar Biosciences Makes Market Debut with Shares Surging Over 34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111071379","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111071379?lang=en_us&edition=fundamental","pubTime":"2026-04-18 00:38","pubTimestamp":1776443894,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR.US) began trading on the U.S. stock market on Friday, with its share price opening more than 34% higher at $22.91. The IPO price was set at $17 per share. Alamar Biosciences...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176686851","title":"Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1176686851","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176686851?lang=en_us&edition=fundamental","pubTime":"2026-04-18 00:37","pubTimestamp":1776443855,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628783958","title":"Alamar Biosciences Shares Open for Trading at $22.6 in Nasdaq Debut VS U.S. IPO Price of $17 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2628783958","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628783958?lang=en_us&edition=fundamental","pubTime":"2026-04-18 00:34","pubTimestamp":1776443685,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nL4N41016L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628195788","title":"BUZZ-Alamar Biosciences set to open above offer price in Nasdaq debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2628195788","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628195788?lang=en_us&edition=fundamental","pubTime":"2026-04-17 23:57","pubTimestamp":1776441459,"startTime":"0","endTime":"0","summary":"BUZZ-Alamar Biosciences set to open above offer price in Nasdaq debut** Protein biomarker detection platform Alamar Biosciences ALMR.O on track to open above offer price in Nasdaq debut** Stock recently indicated to open at $22.50 apiece versus $17 offer price** Fremont, California-based ALMR sold about 11.3 million shares in an upsized IPO at top end of $15-$17 marketed range to raise $191.3 million** Proteomics firm develops instruments to detect low-level protein biomarkers in blood, enabling disease research and diagnostics** J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners and Stifel acted as joint book-running managers for offering  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nL6N410108:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU2129689514.USD","LU2133065610.SGD","LU0234570918.USD","LU1804176565.USD","MNSH","LU0320765489.SGD","LU0320765646.SGD","LU1496350171.SGD","LU2129689605.HKD","SF","LU2129689431.USD","LU0648001328.SGD","BK4588","LU1496350502.SGD","MDIT","LU1280957306.USD","IE00BLSP4239.USD","LU0321505439.SGD","LU0070302665.USD","LU0640476718.USD","LU1035773651.USD","LU0130518102.USD","LU1366192091.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU0203347892.USD","LU2265009873.SGD","LU0477156797.USD","LU1880398554.USD","LU0787776722.HKD","LU0477156953.USD","BAC","LU0130517989.USD","LU0980610538.SGD","LU0256863902.USD","LU1883839398.USD","LU1791807156.HKD","LU0321505868.SGD","LU1506573853.SGD","IE00B1BXHZ80.USD","LU1074936037.SGD","IE00BLSP4452.SGD","LU0053666078.USD","IE00B7SZLL34.SGD","LU0314106906.USD","IE0001KFT4U8.USD","LU0170899867.USD","ALMR","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628701002","title":"Alamar Biosciences 11.25M share IPO priced at $17.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2628701002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628701002?lang=en_us&edition=fundamental","pubTime":"2026-04-17 18:35","pubTimestamp":1776422112,"startTime":"0","endTime":"0","summary":"The deal size was increased to 11.25M shares of common stock from 9.375M shares of common stock and priced at the high-end of the $15.00-$17.00 ran...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-11-25m-share-ipo-priced-at-17-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-11-25m-share-ipo-priced-at-17-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR","SPCX","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628227193","title":"Alamar Biosciences Prices Upsized IPO at $17 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2628227193","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628227193?lang=en_us&edition=fundamental","pubTime":"2026-04-17 16:57","pubTimestamp":1776416236,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) said Friday it has priced its upsized initial public offering of 11.3 million common shares at $17 per share, for gross proceeds of approximately $191.3 million.Underwriters ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR","SPCX","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627211129","title":"Alamar Biosciences Sets IPO at 9.4 Million Shares Priced at $15-$17 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2627211129","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627211129?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:41","pubTimestamp":1776350460,"startTime":"0","endTime":"0","summary":"Alamar Biosciences on Thursday said it plans to sell nearly 9.4 million shares at between $15 and $17 apiece in its initial public offering.At the $16 midpoint of that range, the Fremont, Calif., proteomics company  said it expects net proceeds of about $133.2 million, or roughly $154.1 million if the underwriters exercise an option to buy an additional 1.41 million shares.Alamar said it would have about 66.3 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization of roughly $1.06 billion at the $16-a-share pricing midpoint.The company said it has applied to list its shares on the Nasdaq Global Select Market under the symbol ALMR.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPCX","ALMR","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alamarbio.com","stockEarnings":[{"period":"1week","weight":-0.0551},{"period":"1month","weight":0.3918},{"period":"ytd","weight":0.3918}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Alamar Biosciences","nameEN":"Alamar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alamar Biosciences,ALMR,Alamar Biosciences股票,Alamar Biosciences股票老虎,Alamar Biosciences股票老虎国际,Alamar Biosciences行情,Alamar Biosciences股票行情,Alamar Biosciences股价,Alamar Biosciences股市,Alamar Biosciences股票价格,Alamar Biosciences股票交易,Alamar Biosciences股票购买,Alamar Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}